Natasha Gautam Seth 1 , Sushmita Kaushik 1 , Savleen Kaur 1 , Srishti Raj 1 , Surinder Singh Pandav 1 . Show Affiliations »
Abstract
BACKGROUND: Assessment of spectral-domain optical coherence tomography (SD-OCT) compared with visual fields, to detect progression across the glaucoma spectrum. METHODS: In this study, adult glaucoma suspects and patients, with baseline retinal nerve fibre layer (RNFL) thickness on SD-OCT and reliable visual field (VF) tests on Humphrey Field Analyser (HFA) prior to March 2010, were recruited. Functional and structural progression over at least 5 years was compared using Glaucoma Progression Analysis (GPA) and VF index (VFI) on HFA and Guided Progression Analysis (GPA-OCT) on SD-OCT, respectively. Agreement of progression detection between the two modalities was computed using κ statistics. RESULTS: 122 subjects (63 glaucoma suspects; 59 glaucoma patients) were enrolled. Of 18 suspects who progressed to glaucoma, 13 showed progression by GPA-OCT, 4 by GPA, 7 by VFI and 2 were concordant. In the 14 glaucoma patients who progressed, GPA-OCT detected progression in 6, GPA in five and VFI in six. GPA-OCT had poor agreement with GPA in glaucoma suspects (Kappa 0.15; p=0.13) and patients (Kappa 0.10; p=0.45). VFI had better agreement with GPA-OCT in glaucoma suspects (Kappa 0.34; p=0.01) than glaucoma patients (Kappa 0.12; p=0.36). Progressors by VF in both groups had similar percentage change from baseline RNFL thickness (-9.9% vs -8.6% p=0.46), even though the absolute change was significantly greater in suspects(-8.75µ vs-6.4µ p=0.03). CONCLUSION: Structural change appears to be more useful to detect progression in glaucoma suspects, while functional change is a better indicator as the disease progresses. Percentage change from baseline RNFL thickness was a better measure than absolute change in RNFL. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
BACKGROUND: Assessment of spectral-domain optical coherence tomography (SD-OCT ) compared with visual fields, to detect progression across the glaucoma spectrum. METHODS: In this study, adult glaucoma suspects and patients , with baseline retinal nerve fibre layer (RNFL) thickness on SD-OCT and reliable visual field (VF ) tests on Humphrey Field Analyser (HFA) prior to March 2010, were recruited. Functional and structural progression over at least 5 years was compared using Glaucoma Progression Analysis (GPA ) and VF index (VFI) on HFA and Guided Progression Analysis (GPA -OCT ) on SD-OCT , respectively. Agreement of progression detection between the two modalities was computed using κ statistics. RESULTS: 122 subjects (63 glaucoma suspects; 59 glaucoma patients ) were enrolled. Of 18 suspects who progressed to glaucoma , 13 showed progression by GPA -OCT , 4 by GPA , 7 by VFI and 2 were concordant. In the 14 glaucoma patients who progressed, GPA -OCT detected progression in 6, GPA in five and VFI in six. GPA -OCT had poor agreement with GPA in glaucoma suspects (Kappa 0.15; p=0.13) and patients (Kappa 0.10; p=0.45). VFI had better agreement with GPA -OCT in glaucoma suspects (Kappa 0.34; p=0.01) than glaucoma patients (Kappa 0.12; p=0.36). Progressors by VF in both groups had similar percentage change from baseline RNFL thickness (-9.9% vs -8.6% p=0.46), even though the absolute change was significantly greater in suspects(-8.75µ vs-6.4µ p=0.03). CONCLUSION: Structural change appears to be more useful to detect progression in glaucoma suspects, while functional change is a better indicator as the disease progresses. Percentage change from baseline RNFL thickness was a better measure than absolute change in RNFL. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Entities: Chemical
Disease
Gene
Species
Keywords:
GPA; glaucoma progression; retinal nerve fibre layer
Mesh: See more »
Year: 2017
PMID: 28939691 DOI: 10.1136/bjophthalmol-2017-310731
Source DB: PubMed Journal: Br J Ophthalmol ISSN: 0007-1161 Impact factor: 4.638